SecBot SecBot
144 ·Filed Nov 5, 2026

PGNY

Progyny, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed11d 7h ago SEC0001950047-26-010734
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

Form 144 is an intent to sell, not a completed transaction. Monitor subsequent Form 4 filings to confirm whether the sale actually occurred and at what price. The three-month window for option exercise and sale suggests potential ongoing selling pressure.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$34.84
T+0 close · Nov 5, 2026 · via day close
Latest settled
+3.85%
T+5 · $36.18
Vs SPY
+1.25%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $34.84entry
  2. T+1 · 8d ago +3.19%α +0.82% · $35.95
  3. T+5 · 4d ago +3.85%α +1.25% · $36.18
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Peter Anevski filed a Form 144 notice of intent to sell 314,738 shares of Progyny common stock, valued at approximately $9.47 million based on the filing date. The shares are to be received upon exercise of stock options over the next three months, with the sale intended to occur on or after November 5, 2026.

Key Facts

  • CEO Peter Anevski filed Form 144 to sell 314,738 shares of common stock
  • Estimated aggregate value of shares: $9,473,613.80
  • Shares to be acquired via exercise of stock options over the next three months
  • Sale intended to occur on or after November 5, 2026
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services

Financial Impact

CEO intends to sell ~$9.5 million worth of shares, representing a notable portion of his holdings but the exact percentage of total holdings is not disclosed in the filing.

dilutioninsider ownership

Risk Factors

  • Insider selling by CEO may signal lack of confidence or personal liquidity needs
  • Sale of 314,738 shares could represent meaningful dilution if executed in a short period
  • Form 144 is only an intent notice; the sale may not materialize

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010734
Document: 0001950047-26-010734-index.html0001950047-26-010734
Document: 0001950047-26-010734.txt0001950047-26-010734

Track record

26 reports on PGNY

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +6.43% at T+5 after the Nov 4, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $36.75 Now $37.15 +1.09% settles Nov 23
  2. Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
  4. Nov 10, 20266d ago 144 Neutral 3/10 Entry $36.50 Now $37.15 +1.78% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
  6. Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
  7. Nov 5, 202611d ago 144 Neutral 2/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
  8. Nov 5, 202611d ago 144 Neutral 3/10 Viewing Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
  9. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  10. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (9h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026